Morrison (medicine and radiology, U. of Arizona) and colleagues provide a cardiac surgeon's and interventionalist's perspectives on such risky procedures as coronary angioplasty, and address the issue of medically refractory patients. Contributors to 37 chapters treat drug therapies; the benefits of revascularization (i.e., coronary bypass); a comparison of angioplasty to bypass grafting; risks and benefits for patient subgroups; comorbidity; revascularization enhancements; post-surgery relapse reduction; and medical vs. surgical management of unstable angina. Serruys is an interventional cardiologist at Erasmus U., Rotterdam. Distributed in the US by Taylor & Francis. Annotation (c) Book News, Inc., Portland, OR (booknews.com)
